Journal Guide

Molecular Diversity presents refereed papers describing the development, application and theory of molecular diversity, and combinatorial chemistry in basic and applied research and drug discovery. The journal publishes both short and full-length papers, perspectives, news and reviews. Coverage addresses the generation of molecular diversity, application of diversity for screening against alternative targets of all types, analysis of results and their application in various scientific disciplines. Topics include combinatorial chemistry and parallel synthesis; small molecule libraries; microwave synthesis; flow synthesis; fluorous synthesis; diversity oriented synthesis (DOS); nanoreactors; click chemistry; multiplex technologies; fragment- and ligand-based design; structure/function/SAR; computational chemistry and molecular design; chemoinformatics; screening techniques and screening interfaces; analytical and purification methods; robotics, automation and miniaturization; targeted libraries; display librar

Molecular Genetics & Genomic Medicine is a peer-reviewed journal for rapid dissemination of quality research related to the dynamically developing areas of human, molecular and medical genetics. The journal publishes original research articles covering findings in phenotypic, molecular, biological, and genomic aspects of genomic variation, inherited disorders and birth defects. The broad publishing spectrum of Molecular Genetics & Genomic Medicine includes rare and common disorders from diagnosis to treatment. Examples of appropriate articles include reports of novel disease genes, functional studies of genetic variants, in-depth genotype-phenotype studies, genomic analysis of inherited disorders, molecular diagnostic methods, medical bioinformatics, ethical, legal, and social implications (ELSI), and approaches to clinical diagnosis. Molecular Genetics & Genomic Medicine provides a scientific home for next generation sequencing studies of rare and common disorders, which will make research in this fascinating area easily and rapidly accessible to the scientific community. This will serve as the basis for translating next generation sequencing studies into individualized diagnostics and therapeutics, for day-to-day medical care.

Molecular Genetics & Genomic Medicine publishes original research articles, reviews, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented.

Molecular Genetics & Genomic Medicine is a Wiley Open Access journal, one of a series of peer reviewed titles publishing quality research with speed and efficiency. Authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content. The author grants Wiley a license to publish the article and identify as the original publisher. To find out which Created Commons Licenses are available for the journal, click here. For further information, visit the Wiley Open Access website.

The First Journal on Genetics, founded in 1908
Molecular Genetics and Genomics (MGG) publishes peer-reviewed articles covering all areas of genetics and genomics. Any approach to the study of genes and genomes is considered, be it experimental, theoretical or synthetic. MGG publishes research on all organisms that is of broad interest to those working in the fields of genetics, genomics, biology, medicine and biotechnology.

Molecular Genetics and Metabolism is a contribution to the understanding of the metabolic basis of disease. The journal publishes articles describing investigations that use the tools of biochemistry and molecular biology for studies of normal and diseased states. In addition to original research articles, occasional minireviews reporting timely advances as well as brief communications and letters to the editor are considered.Research Areas include:• Inherited Metabolic Diseases:- Biochemical studies of primary enzyme defects- Molecular genetic analyses of mutations- Pathogenesis of these disorders, including not only primary but also secondary metabolic alterations• Systems Biology:- Functional integration of biochemical network modules- Moonlighting functions of proteins• Intercellular and Intracellular Metabolic Relationships:- Biochemical interactions between cells- Functional roles of and interactions between subcellular compartments and distinct regions within these cellular spaces, termed microcompartments- Metabolic relations between individual enzymes and pathways• Cellular Catalysts:- Protein and nonprotein catalyst in normal and deranged cellular metabolism- Relationships between the structure and function of catalytic molecules- Interaction of these catalysts with other cellular components• Disease Pathogenesis:- Underlying mechanisms of inherited and acquired diseases- Relationships between genotype and phenotype at the biochemical and molecular levels• Treatment:- Drug, protein and dietary interventions- Transplantation and gene therapy- Multicenter clinical trialsAdvances in nanomedicine, nanopediatrics and nanotechnology are also welcome.

Molecular Genetics, Microbiology and Virology addresses theoretical and applied topics in molecular genetics of pro- and eukaryotes, molecular microbiology and molecular virology. The journal focuses on studies of the genetic apparatus of microorganisms, the search for genetic forms of metabolism, genetic mapping of pathogenic causative agents, investigations of the structure and functions of extrachromosomal factors of heredity and migratory genetic elements, and theoretical studies on the mechanisms of genetic regulation. Topics include the molecular and genetic elements of eukaryotic cells, the function of chromosomes and chromatin, the nature of genetic changes in malignant degeneration, hereditary diseases. Also covered are the molecular bases of virology, including viral and cellular genomes integration and viral persistence. The journal's scope of coverage includes the biotechnological production of hormones, components of antiviral vaccines, and diagnostic and therapeutic preparations.

MHR publishes articles on the molecular aspects of human reproductive physiology and pathology, endocrinology, andrology,gonadal function, gametogenesis, fertilization, embryo development, implantation, pregnancy and contraception. Reproductive genetics is also an important part of MHR. Studies on animal models are welcome as long as a clear relevance to human reproduction can be shown. Published papers include peer-reviewed original research reports, short review articles and commentaries. MHR is published on behalf of the European Society of Human Reproduction and Embryology.

Molecular Imaging and Biology presents original research contributions on the utilization of molecular imaging in problems of relevance in biology and medicine. The primary objective of the journal is to provide a forum for the discovery of molecular mechanisms of health and disease through the use of imaging techniques. Among the topics covered are molecular imaging investigations of macromolecular targets involved in significant biological processes; design and evaluation of molecular probes used to investigate macromolecular targets and their functions; and study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics.The overall goal is to translate basic science discoveries into molecular imaging of disease in patients, both to investigate the biological nature of disease in actual patients and to establish new molecular imaging diagnostic procedures.Molecular Imaging and Biology is the official journal of the World Molecular Imaging Society and the Europea

Molecular Medicine is the international, peer-reviewed, biomedical journal published by the Feinstein Institute for Medical Research (New York). Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine. The 2011 Journal Citation Report (JCR), showing impact factors calculated from citations of articles published in 2010 and 2009, lists Molecular Medicine with an impact factor of 3.757. JCR category rankings are as follows: Medicine, Research & Experimental 24/111, Cell Biology 72/180, Biochemistry & Molecular Biology 91/289. Molecular Medicine publishes work in the format of original research articles, review articles, editorials, commentaries and letters to the editor covering emerging concepts in the interdisciplinary field of molecular medicine.Molecular Medicine places high priority on rapid publication. All content is published free online, ahead of print, within an average of 8 days after acceptance on our Web site www.molmed.org. Following acceptance, papers are posted rapidly to PubMed, with an e-publication ahead of print citation. Molecular Medicine is an open access journal and does not embargo content.

* Biological Abstracts® (Thomson ISI) * BIOSIS Previews® (Thomson ISI) * Chemical Abstracts Service (CAS) * EMBASE (Elsevier) * Google Scholar * Index Copernicus (IC) * Index Medicus/MEDLINE/PubMed (NLM) * Journal Citation Reports (JCR) Science Edition (Thomson ISI) * Science Citation Index Expanded® (Thomson ISI) * Scopus (Elsevier).

Molecular Neurodegeneration is ready to receive manuscripts on all aspects of neurodegeneration research at the molecular and cellular levels.

Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. Topics include:• Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.• Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.•Biomarkers: diagnosis, prognosis, stratification and efficacy.• Cancer genetics, epigenetics, and genomic instability.• Minimal residual disease, pre-malignant lesions.• Cancer micro-environment.• Molecular pathology.• Tumour immunology.• Translational research.• Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment).• Chemotherapy, radiotherapy and surgery.• Clinical pharmacology.• Clinical trials, integration of basic science into cancer clinical trials.• Epidemiology and prevention.• Infrastructures (biobanks, databases, genomic resources).A main feature of the Journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.Coverage: Reviews, original articles, technical notes, editorials, news & views (commentary, science policy issues, ethical and legal issues, patient organisations, industry needs and alliances, regulatory issues, news items), letters to the editor, conference announcements, advertisements.Submitting Authors:Manuscripts can be submitted to Molecular Oncology at:http://ees.elsevier.com/molonc/

molecular oral microbiology publishes high quality research papers and reviews on fundamental or applied molecular studies of microorganisms of the oral cavity and respiratory tract, host-microbe interactions, cellular microbiology, molecular ecology, and immunological studies of oral and respiratory tract infections.Papers describing work in virology, or in immunology unrelated to microbial colonization or infection, will not be acceptable.

Molecular Pain is ready to receive manuscripts on all aspects of pain research at the cellular, subcellular and molecular levels. Molecular Pain is sponsored by the University of Cincinnati College of Medicine.

MPMI has instituted a feature called First Look. Within a few days of acceptance, papers by authors who choose to participate will be posted online. The papers have been peer reviewed and then revised as necessary by the authors but have not been copyedited, formatted, or assigned to an issue.The date on which each paper is posted is considered the publication date. The papers are fully citable by doi.The following statement appears on papers posted in First Look:MPMI "First Look" paper • doi: 10.1094/MPMI-00-00-0000 • posted 00/00/201XThis paper has been peer reviewed and accepted for publication but has not yetbeen copyedited or proofread. The final published version may differ.

Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment. The emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging and psychopharmacology levels.

Molecular Syndromology publishes high-quality research articles, short reports, and reviews on common and rare genetic syndromes, aiming to increase clinical understanding through molecular insights. Topics of particular interest are the molecular basis of genetic syndromes, genotype-phenotype correlation, natural history, strategies in disease management and novel therapeutic approaches based on molecular findings. Research on model systems is also welcome, especially when it is obviously relevant to human genetics. With high-quality reviews on current topics, the journal aims to facilitate translation of research findings to a clinical setting while also stimulating further research on clinically relevant questions. The journal targets not only medical geneticists and basic biomedical researchers, but also clinicians dealing with genetic syndromes. With 4 associate editors from 3 continents and a broad international editorial board, the journal welcomes submissions covering the lates

Molecular systems biology is an integrative discipline that seeks to explain the properties and behaviour of complex biological systems in terms of their molecular components and their interactions.Molecular Systems Biology is a peer-reviewed author-pays online journal that publishes full-length papers and accompanying synopses describing original research in the field of molecular systems biology and which focuses on the analysis, integration and modeling of molecular and cellular phenomena. Since molecular systems biology relies on a variety of computational and high-throughput technologies, the journal makes full use of the online to allow reader interaction with data and models presented in the published articles.Topics falling within the scope of the journal include, but are not limited to:* Proteomics* Metabolomics* Functional genomics* Structural genomics* Transcriptomics* Computational biology* Bioinformatics* Theoretical biology* Synthetic biologyMolecular Systems Biology aims to provide:The most integrative coverage: Molecular Systems Biology facilitates the integration of the individual subject areas that make up the overall field of molecular systems biology by ensuring that all research papers are accessible to all readers. This is done in three main ways:* All papers have a brief 'synopsis', which explains the findings and significance of the research. These will be written by the authors, with help from in-house editorial staff* Many papers are covered by News and Views articles. These are written by experts in the field and aim to place the research in a broader context* Rich linking from papers allows readers access to related databases and other web resourcesA forum for setting standards: The world-class Senior Editors and editorial board of Molecular Systems Biology will enable the journal to become a forum for the publication of papers that set the standards in this emerging field. Papers that aim to do this will be given special consideration, and readers will be encouraged to comment on the journal's 'feedback forum'.Unparalleled editorial support: No other journal in the field of systems biology offers the same level of editorial support as Molecular Systems Biology. Our in-house PhD-qualified editorial staff will work with the authors of all research papers to ensure that the synopses and manuscripts are as accessible and readable as possible, and they will commission accompanying 'News & Views' and review articles.The latest technological developments: Molecular Systems Biology is first journal from the Nature Publishing Group stable to accept data in the systems biology mark-up language (SBML) format. The journal also features:* RSS alerts for instant notification when new papers are published.

Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide- and protein-, oligonucleotide- and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Available in print and online, Molecular Therapy is dedicated to promoting the sciences in genetics, medicine and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2009 impact factor is 6.239*.

methods, technology development, molecular therapy, gene therapy